Webisodes

Clarity on Comparative Effectiveness: How and When Will It Be Used by Payers

Gain insight on how comparative effectiveness may be rolled out in the United States, how it will differ from models in Europe and Canada and what other utilization management initiatives may be on the horizon. Bob Mauch, president of Xcenda, discusses this and what pharma can do to ensure continued product success and patient access to medications.